Hippocampal mechanisms linking chronic pain and depression

Journal of Neuropathic Pain and Symptom Palliation

Volumn 2, Issue 4, 2008, Pages 15-32

  Duric, Vanja ^a,c   McCarson, Kenneth E ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; BDNF; Neurogenesis; Neurokinin 1 receptors; Nociception; Stress

Indexed keywords

EID: 68949124787     PISSN: 15437698     EISSN: 15437701     Source Type: Journal    
DOI: 10.1300/J426v02n04_03     Document Type: Article

References (149)

1. Andsrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, Dragomirecka E, Kohn R, Keller M, Kessler RC, Kawakami N, Kilic C,Offord D, Ustun TB and Wittchen HU(2003). The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology(ICPE) Surveys. Int J Methods Psychiatr Res 12:3-21.
2. Apfel SC, Wright DE, Wiideman AM, Dormia C,Snider WD and Kessler JA(1996). Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system. Mol Cell Neurosci 7:134-142.
3. Atkinson JH, Slater MA, Wahlgren DR, Williams RA,Zisook S, Pruitt SD, Epping-Jordan JE, Patterson TL, Grant I, Abramson I and Garfin SR(1999). Effects of noradrenergic and serotonergic antidepres- sants on chronic low back pain intensity. Pain 83:137-145.
4. Bair MJ, Robinson RL, Katon W and Kroenke K(2003). Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433-2445.
5. Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM and Tracey I(2002). Imaging how attention modulates pain in humans using functional MRI. Brain 125:310-319.
6. Bar KJ, Brehm S, Boettger MK, Boettger S, Wagner G and Sauer H(2005). Pain perception in major depression depends on pain modality. Pain 117:97-103.
7. Bar KJ, Greiner W, Letsch A, Kobele R and Sauer H(2003). Influence of gender and hemispheric lateralization on heat pain perception in major depression. J Psychiatr Res 37:345-353.
8. Basbaum AI and Fields HL(1984). Endogenous pain control systems: brainstem spinal pathways and en- dorphin circuitry. Annu Rev Neurosci 7:309-338. Bauerova K, Nosal'ova V, Mihalova D and Navarova J(2004). Contribution to safe anti-inflammatory therapy with indomethacin. Cent Eur J Public Health 12 Suppl:S8-10.
9. Bechara A, Tranel D, Damasio H, Adolphs R, Rockland C and Damasio AR(1995). Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science 269:1115-1118.
10. Bernard JF and Bandler R(1998). Parallel circuits for emotional coping behaviour: new pieces in the puzzle. J Comp Neurol 401:429-436. Bernard JF, Bester H and Besson JM(1996). Involvement of the spino-parabrachio -amygdaloid and -hy- pothalamic pathways in the autonomic and affective emotional aspects of pain. Prog Brain Res 107:243-255.
11. Blackburn-Munro G and Blackburn-Munro RE(2001). Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol 13: 1009-1023.
12. Bremner JD, Randall P, Scott TM, Bronen RA, Seibyl JP, Southwick SM, Delaney RC, McCarthy G, Charney DS and Innis RB(1995). MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 152:973-981.
13. Bremner JD, Randall P, Vermetten E, Staib L, Bronen RA, Mazure C, Capelli S, McCarthy G, Innis RB and Charney DS(1997). Magnetic resonance imag- ing-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse-a preliminary report. Biol Psychiatry 41:23-32.
14. Calza L, Pozza M, Zanni M, Manzini CU, Manzini E and Hokfelt T(1998). Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study. Neuroscience 82:575-589.
15. Cameron HA and McKay RD(1999). Restoring production of hippocampal neurons in old age. Nat Neurosci 2:894-897.
16. Carlezon WA, Jr., Duman RS and Nestler EJ(2005). The many faces of CREB. Trends Neurosci. 24:436-445.
17. Chen AC, Shirayama Y, Shin KH, Neve RL and Duman RS(2001). Expression of the cAMP response element binding protein(CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 49:753-762.
18. Chizh BA, Dickenson AH and Wnendt S(1999). The race to control pain: more participants, more targets. Trends Pharmacol Sci 20:354-357.
19. Cho HJ, Kim JK, Zhou XF and Rush RA(1997a). Increased brain-derived neurotrophic factor immuno- reactivity in rat dorsal root ganglia and spinal cord following peripheral inflammation. Brain Res 764:269-272.
20. Cho HJ, Kim SY, Park MJ, Kim DS, Kim JK and Chu MY(1997b). Expression of mRNA for brain-derived neurotrophic factor in the dorsal root ganglion following peripheral inflammation. Brain Res 749:358-362.
21. Condorelli DF, Dell'Albani P, Mudo G, Timmusk T and Belluardo N(1994). Expression of neurotrophins and their receptors in primary astroglial cultures: induction by cyclic AMP-elevating agents. J Neurochem 63:509-516.
22. Craig AD(1995). Distribution of brainstem projections from spinal lamina I neurons in the cat and the monkey. J Comp Neurol 361:225-248.
23. Currie SR and Wang J(2004). Chronic back pain and major depression in the general Canadian population. Pain 107:54-60.
24. Damasio A(2003). Feelings of emotion and the self.Ann N YAcad Sci 1001:253-261.
25. Damasio AR(1995). Consciousness. Knowing how,knowing where. Nature 375:106-107.
26. Damasio AR(1998). Emotion in the perspective of an integrated nervous system. Brain Res Brain Res Rev 26:83-86.
27. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F and Hunt SP(1998). Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392:394-397.
28. Ding YQ, Takada M, Shigemoto R and Mizumo N(1995). Spinoparabrachial tract neurons showing substance P receptor-like immunoreactivity in the lumbar spinal cord of the rat. Brain Res 674:336-340.
29. Duman RS(2002). Structural alterations in depression: cellular mechanisms underlying pathology and treatment of mood disorders. CNS Spectr 7:140-142, 144-147.
30. Duman RS(2004). Neural Plasticity: consequences of stress and actions of antidepressant treatment. Dialogues in Clinical Neuroscience 6:157-169.
31. Duman RS and Charney DS(1999). Cell atrophy and loss in major depression. Biol Psychiatry 45:1083-1084.
32. Duman RS, Heninger GR and Nestler EJ(1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
33. Duman RS, Malberg J and Nakagawa S(2001a). Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther 299:401-407. (Pubitemid 32979649)
34. Duman RS, Nakagawa S and Malberg J(2001b). Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25:836-844. (Pubitemid 34031890)
35. Duric V and McCarson KE(2005). Hippocampal neuro- kinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models ofpain and stress. Neuroscience 133:999-1006.
36. Duric V and McCarson KE(2006a). Effects ofanalgesic or antidepressant drugs on pain- or stress-evoked hippocampal and spinal neurokinin-1(NK-1) receptor and brain-derived neurotrophic factor(BDNF) gene expression in the rat. J Pharmacol Exp Ther. 319:1235-1243.
37. Duric V and McCarson KE(2006b). Persistent Pain Produces Stress-like Alterations in Hippocampal Neuro- genesis and Gene Expression. J Pain 7:544-555.
38. Engel CC, Jr., Walker EA, Engel AL, Bullis J and Armstrong A(1998). A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res 44:203-207.
39. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA and Gage FH(1998). Neurogenesis in the adult human hippocampus. Nat Med 4:1313-1317.
40. Fishbain DA, Cutler R, Rosomoff HL and Rosomoff RS(1997). Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13:116-137.
41. Ford DE and Kamerow DB(1989). Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 262:1479-1484.
42. Friedman DP, Murray EA, O'Neill JB and Mishkin M(1986). Cortical connections of the somatosensory fields of the lateral sulcus of macaques: evidence for a corticolimbic pathway for touch. J Comp Neurol 252:323-347.
43. Ghosh A, Carnahan J and Greenberg ME(1994). Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618-1623.
44. Ghosh A and Greenberg ME(1995). Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268:239-247.
45. Gould E, Cameron HA, Daniels DC, Woolley CS and McEwen BS(1992). Adrenal hormones suppress cell division in the adult rat dentate gyrus. J Neurosci 12:3642-3650.
46. Gould E and Tanapat P(1999). Stress and hippocampal neurogenesis. Biol Psychiatry 46:1472-1479.
47. Gould E, Tanapat P, McEwen BS, Flugge G and Fuchs E(1998). Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci U S A 95:3168-3171. (Pubitemid 28135873)
48. Groth R and Aanonsen L(2002). Spinal brain-derived neurotrophic factor(BDNF) produces hyperalgesia in normal mice while antisense directed against either BDNF or trkB, prevent inflammation-induced hyperalgesia. Pain 100:171-181.
49. Gurvits TV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, Orr SP, Kikinis R, Jolesz FA, McCarley RW and Pitman RK(1996). Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 40:1091-1099.
50. Henry JL(1976). Effects of substance P on functionally identified units in cat spinal cord. Brain Res 114:439-451.
51. Henry JL(1993). Substance P and inflammatory pain: potential of substance P antagonists as analgesics. Agents Actions Suppl 41:75-87.
52. Hunt SP andMantyh PW(2001). The molecular dynamics of pain control. Nat Rev Neurosci 2:83-91.
53. Isaacson RL(1992). A fuzzy limbic system. Behav Brain Res 52:129-131.
54. Julius D and Basbaum AI(2001) Molecular mechanisms of nociception. Nature 413:203-210.
55. Kessler RC, Berglund P, Demler O, Jin R, Koretz D,Merikangas KR, Rush AJ, Walters EE and Wang PS(2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication(NCS-R). Jama 289:3095-3105.
56. Khasabov SG, Rogers SD, Ghilardi JR, Peters CM,Mantyh PW and Simone DA(2002). Spinal neurons that possess the substance P receptor are required for the development of central sensitization. J Neurosci 22:9086-9098.
57. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D,Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M,Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ and Rupniak NM(1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:10640-11645
58. Kundermann B, Krieg JC, Schreiber W and Lauten- bacher S(2004). The effect of sleep deprivation on pain. Pain Res Manag 9:25-32.
59. Lathe R(2001). Hormones and the hippocampus. J Endocrinol 169:205-231.Lautenbacher S and Krieg JC(1994). Pain perception in psychiatric disorders: a review of the literature. J Psychiatr Res 28:109-122.
60. Lautenbacher S, Spernal J, Schreiber W and Krieg JC(1999). Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med 61:822-827.
61. Lee SL, Kim JK, Kim DS and Cho HJ(1999). Expression of mRNAs encoding full-length and truncated TrkB receptors in rat dorsal root ganglia and spinal cord following peripheral inflammation. Neuroreport 10:2847-2851.
62. Leo RJ and Barkin RL(2003). Antidepressant Use in Chronic Pain Management: Is There Evidence of a Role for Duloxetine? Prim Care Companion J Clin Psychiatry 5:118-123.
63. Lindsay RM, Wiegand SJ, Altar CA and DiStefano PS(1994). Neurotrophic factors: from molecule to man. Trends Neurosci 17:182-190.
64. Lindvall O, Kokaia Z, Bengzon J, Elmer E and Kokaia M(1994). Neurotrophins and brain insults. Trends Neurosci 17:490-496.
65. Lo DC(1995). Neurotrophic factors and synaptic plasticity. Neuron 15:979-981.
66. Lopez JF, Chalmers DT, Little KY and Watson SJ(1998). A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43:547-573.
67. Lynch ME(2001). Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 26:30-36.
68. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O and Tingstrom A(2000). Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47:1043-1049.
69. Maeno H, Kiyama H and Tohyama M(1993). Distribution of the substance P receptor(NK-1 receptor) in the central nervous system. Brain Res Mol Brain Res 18:43-58.
70. Magni G, Caldieron C, Rigatti-Luchini S and Merskey H(1990). Chronic musculoskeletal pain and depressive symptoms in the general population. An analysis of the 1st National Health and Nutrition Examination Survey data. Pain 43:299-307.
71. Magni G, Marchetti M, Moreschi C, Merskey H and Luchini SR(1993). Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study. Pain 53:163-168.
72. Maizels M and McCarberg B(2005). Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 71:483-490.
73. Malberg JE, Eisch AJ, Nestler EJ and Duman RS(2000).Chronic antidepressant treatment increases neuro- genesis in adult rat hippocampus. J Neurosci 20:9104-9110.
74. Malcangio M and Lessmann V(2003). A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors. Trends Pharmacol Sci 24:116-121.
75. Manchikanti L, Fellows B and Singh V(2002). Understanding psychological aspects of chronic pain in interventional pain management. Pain Physician 5:57-82.
76. Mannion RJ, Costigan M, Decosterd I, Amaya F, Ma QP, Holstege JC, Ji RR, Acheson A, Lindsay RM,Wilkinson GA and Woolf CJ(1999). Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensi-tivity. Proc Natl Acad Sci U S A 96:9385-9390.
77. Mantyh PW(1983). The terminations of the spino- thalamic tract in the cat. Neurosci Lett 38:119-124.
78. Mantyh PW(2002). Neurobiology of substance P and the NK1 receptor. J Clin Psychiatry 63 Suppl 11:6-10.
79. Matsumoto N, Bester H, Menendez L, Besson JM and Bernard JF(1996). Changes in the responsiveness of parabrachial neurons in the arthritic rat: an electro- physiological study. J Neurophysiol 76:4113-4126.
80. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B and DubnerR(1992). Effects of desipramine, amitriptyl- ine, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 326:1250-1256.
81. McCarson KE and Krause JE(1994). NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J Neurosci 14:712-720.
82. McCarson KE and Krause JE(1995). The formalin-induced expression of tachykinin peptide and neuro- kinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration. Neuroscience 64:729-739.
83. McCarson KE and Krause JE(1996). The neurokinin-1 receptor antagonist LY306,740 blocks nociception- induced increases in dorsal horn neurokinin-1 receptor gene expression. Mol Pharmacol 50:1189-1199.
84. McEwen BS(1999) Stress and hippocampal plasticity. Annu Rev Neurosci 22:105-122.
85. McEwen BS, Cameron H, Chao HM, Gould E,Magarinos AM,WatanabeY and Woolley CS(1993) Adrenal steroids and plasticity of hippocampal neurons: toward an understanding of underlying cellular and molecular mechanisms. Cell Mol Neurobiol 13:457-482.
86. McKenna JE and Melzack R(1992). Analgesia produced by lidocaine microinjection into the dentate gyrus. Pain 49:105-112.
87. McKenna JE and Melzack R(2001). Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test. Exp Neurol 172:92-99.
88. McQuay HJ, Carroll D and Glynn CJ(1993). Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia 48:281-285.
89. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ and Moore RA(1996). A systematic review of anti- depressants in neuropathic pain. Pain 68:217-227.
90. Melzack R and Wall PD(1965). Pain mechanisms: a new theory. Science 150:971-979.
91. Menendez L, Bester H, Besson JM and Bernard JF(1996). Parabrachial area: electrophysiological evidence for an involvement in cold nociception. J Neurophysiol 75:2099-2116.
92. Meyer TE and Habener JF(1993). Cyclic adenosine 3',5'-monophosphate response element binding protein(CREB) and related transcription-activating de- oxyribonucleic acid-binding proteins. Endocr Rev 14:269-290.
93. Michael GJ, Averill S, Nitkunan A, Rattray M, Bennett DL, Yan Q and Priestley JV(1997). Nerve growth factor treatment increases brain-derived neuro- trophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J Neurosci 17:8476-8490.
94. Morcuende S, Gadd CA, Peters M, Moss A, Harris EA, Sheasby A, Fisher AS, De Felipe C, Mantyh PW, Rupniak NM, Giese KP and Hunt SP(2003). Increased neurogenesis and brain-derived neurotrophic factor in neurokinin-1 receptor gene knockout mice. Eur J Neurosci 18:1828-1836.
95. Nagakura Y, Okada M, Kohara A, Kiso T, Toya T, Iwai A, Wanibuchi F and Yamaguchi T(2003). Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther 306:490-497.
96. Nibuya M, Morinobu S and Duman RS(1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547.
97. Nibuya M, Nestler EJ and Duman RS(1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB) in rathippocampus. JNeurosci 16:2365-2372.
98. Payan DG(1989). Neuropeptides and inflammation: the role of substance P. Annu Rev Med 40:341-352.
99. Peyron R, Garcia-Larrea L, Gregoire MC, Costes N, Convers P, Lavenne F, Mauguiere F, Michel D and Laurent B(1999). Haemodynamic brain responses to acute pain in humans: sensory and attentional networks. Brain 122(Pt 9):1765-1780.
100. Pezet S, Malcangio M, Lever IJ, Perkinton MS, Thompson SW, Williams RJ and McMahon SB(2002a)Noxious stimulation induces Trk receptor and downstream ERK phosphorylation in spinal dorsal horn.Mol Cell Neurosci 21:684-695.
101. Pezet S, Malcangio M and McMahon SB(2002b).BDNF: a neuromodulator in nociceptive pathways?Brain Res Brain Res Rev40:240-249.
102. Ploghaus A, Tracey I, Clare S, Gati JS, Rawlins JN and Matthews PM(2000). Learning about pain: the neural substrate of the prediction error for aversive events. Proc Natl Acad Sci U S A 97:9281-9286.
103. Price DD(2000). Psychological and neural mechanisms of the affective dimension of pain. Science 288:1769-1772.
104. Radley JJ and Jacobs BL(2002). 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res 955:264-267.
105. Radley JJ and Jacobs BL(2003). Pilocarpine-induced status epilepticus increases cell proliferation in the dentate gyrus of adult rats via a 5-HT1A receptor-dependent mechanism. Brain Res 966:1-12.
106. Rainville P(2002). Brain mechanisms of pain affect and pain modulation. Curr Opin Neurobiol 12:195-204.
107. Reisby N, Gram LF, Bech P, Nagy A, Petersen GO, Ortmann J, Ibsen I, Dencker SJ, Jacobsen O, Krautwald O, Sondergaard I and Christiansen J(1977). Imipramine: clinical effects and pharma- cokinetic variability. Psychopharmacology(Berl)54:263-272.
108. Ruoff GE(1996). Depression in the patient with chronic pain. JFam Pract 43:S25-33; discussion S34.
109. Rupniak NM(2002). Elucidating the antidepressant actions of substance P(NK1 receptor) antagonists. Curr Opin Investig Drugs 3:257-261.
110. Rupniak NM, Carlson EC, Harrison T, Oates B, Seward E, Owen S, de Felipe C, Hunt S and Wheeldon A(2000). Pharmacological blockade or genetic deletion of substance P(NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice. Neuropharmacology 39:1413-1421.
111. Rupniak NM and Kramer MS(1999). Discovery of the antidepressant and anti-emetic efficacy of substance P receptor(NK1) antagonists. Trends Pharmacol Sci 20:485-490.
112. Rush AJ, Polatin P and Gatchel RJ(2000). Depression and chronic low back pain: establishing priorities in treatment. Spine 25:2566-2571. (Pubitemid 30818323)
113. Sandin J, Georgieva J, Schott PA, Ogren SO and Terenius L(1997). Nociceptin/orphanin FQ micro- injected into hippocampus impairs spatial learning in rats. Eur J Neurosci 9:194-197.
114. Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R and Heath MJ(2001). Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci U S A 98:1912-1917.
115. Sapolsky RM(2000). The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48:755-765.
116. Sapolsky RM(2001). Atrophy of the hippocampus in posttraumatic stress disorder: how and when? Hippocampus 11:90-91.
117. Sheline YI, Sanghavi M, Mintun MA and Gado MH(1999). Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19:5034-5043.
118. Sheline YI, Wang PW, Gado MH, Csernansky JG and Vannier MW(1996). Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A93:3908-3913.
119. Shirayama Y, Chen AC, Nakagawa S, Russell DS and Duman RS(2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. JNeurosci 22:3251-3261.
120. Siegel RA, Duker EM, Pahnke U and Wuttke W(1987). Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus. Neuroendocrinology 46:75-81.
121. Siuciak JA, Lewis DR, Wiegand SJ and Lindsay RM(1997). Antidepressant-like effect of brain-derived neurotrophic factor(BDNF). Pharmacol Biochem Behav 56:131-137.
122. Sluka KA, Milton MA, Willis WD and Westlund KN(1997). Differential roles of neurokinin 1 and neuro- kinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br J Pharmacol 120:1263-1273.
123. Smith MA, Makino S, Kvetnansky R and Post RM(1995). Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neuro- trophin-3 mRNAs in the hippocampus. J Neurosci 15:1768-1777.
124. Stein MB, Koverola C, Hanna C, Torchia MG and McClarty B(1997). Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 27:951-959.
125. Sullivan MJ, Reesor K, Mikail S and Fisher R(1992).The treatment of depression in chronic low back pain: review and recommendations. Pain 50:5-13. Takayama H, Ota Z and Ogawa N(1986). Effect of immobilization stress on neuropeptides and their receptors in rat central nervous system. Regul Pept 15:239-248.
126. Teather LA, Afonso VM and Wurtman RJ(2006). Inhibition of platelet-activating factor receptors in hippocampal plasma membranes attenuates the inflammatory nociceptive response in rats. Brain Res 1097:230-233.
127. Thoenen H(1995). Neurotrophins and neuronal plasticity. Science 270:593-598.
128. Thompson SW, Bennett DL, Kerr BJ, Bradbury EJ and McMahon SB(1999). Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord. Proc Natl Acad Sci U S A 96:7714-7718.
129. Tracey I, Becerra L, Chang I, Breiter H, Jenkins L, Borsook D and Gonzalez RG(2000). Noxious hot and cold stimulation produce common patterns of brain activation in humans: a functional magnetic resonanceimagingstudy. NeurosciLett288:159-162.
130. Urban MO and Gebhart GF(1999a) Central mechanisms in pain. Med Clin North Am 83:585-596.
131. Urban MO and Gebhart GF(1999b) Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci U S A96:7687-7692.
132. Vaidya VA, Siuciak JA, Du F and Duman RS(1999). Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 89:157-166.
133. van Praag H, Christie BR, Sejnowski TJ and Gage FH(1999). Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc Natl Acad Sci U S A 96:13427-13431.
134. van Praag H, Kempermann G and Gage FH(2000). Neural consequences of environmental enrichment. Nat Rev Neurosci 1:191-198.
135. Vaught JL(1988). Substance P antagonists and analgesia: areviewofthehypothesis. LifeSci43:1419-1431.
136. Von Korff M, Dworkin SF, Le Resche L and Kruger A(1988). An epidemiologic comparison of pain complaints. Pain 32:173-183.
137. Von Korff M and Simon G(1996). The relationship between pain and depression. Br J Psychiatry Suppl:101-108.
138. Warner-Schmidt JL and Duman RS(2006). Hippo- campal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16:239-249.
139. Watanabe Y, Gould E and McEwen BS(1992). Stressinduces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res 588:341-345.
140. Wei F, Xu ZC, Qu Z, Milbrandt J and Zhuo M(2000).Role of EGR1 in hippocampal synaptic enhancement induced by tetanic stimulation and amputation. JCell Biol 149:1325-1334.
141. Willis WD and Westlund KN(1997). Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 14:2-31. Winter MK and McCarson KE(2005). G-protein activation by neurokinin-1 receptors is dynamically regu-lated during persistent nociception. J Pharmacol Exp Ther.
142. Wolfe F, Cathey MA and Hawley DJ(1994). A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23:255-259.
143. Yokogawa F, Kiuchi Y, Ishikawa Y, Otsuka N, Masuda Y, Oguchi K and Hosoyamada A(2002). An investigation of monoamine receptors involved in antino- ciceptive effects of antidepressants. Anesth Analg 95:163-168.
144. Yu TP, Fein J, Phan T, Evans CJ and Xie CW(1997).Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 7:88-94.
145. Zarrindast MR and Sahebgharani M(2002). Effect of al- pha-adrenoceptor agonists and antagonists on imipramine-induced antinociception in the rat formalin test. Pharmacology 64:201-207.
146. Zhang H, Torregrossa MM, Jutkiewicz EM, Shi YG, Rice KC, Woods JH, Watson SJ and Ko MC(2006). Endogenous opioids upregulate brain-derived neuro- trophic factor mRNA through delta- and micro- opioid receptors independent of antidepressant-like effects. Eur J Neurosci 23:984-994.
147. Zhang RX, Lao L, Wang X, Ren K and Berman BB(2004). Electroacupuncture combined with indo- methacin enhances antihyperalgesia in inflammatory rats. Pharmacol Biochem Behav 78:793-797.
148. Zhang X, Bean AJ, Wiesenfeld-Hallin Z, Xu XJ and Hokfelt T(1995). Ultrastructural studies on peptides in the dorsal horn of the rat spinal cord-III. Effects of peripheral axotomy with special reference to galanin. Neuroscience 64:893-915.
149. Zhou XF and Rush RA(1996). Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons. Neuroscience 74:945-953.